Author

YU Kai-ting

National Yang Ming Chiao Tung University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Chen-Ching LiniD· 1 shared Chunying WuiD· 1 shared Jinn‐Moon YangiD· 1 shared Jiunn-Chang LiniD· 1 shared Muh‐Hwa YangiD· 1 shared Pei-Ching ChangiD· 1 shared Tai‐Ming KoiD· 1 shared Tze-Yun Hu· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Chen-Ching LinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TIGIT-NECTIN2/3 signaling preserves ignorant CD8⁺ T cells for favorable immune checkpoint outcomes in HBV-related hepatocellular carcinoma

Pei-Ching Chang, Zhi-Chen Yan, Yung-Chih Hong, YU Kai-ting, Tze-Yun Hu, Tze-Yun Hu, Chen-Ching Lin, Tai‐Ming Ko, Jinn‐Moon Yang, Muh‐Hwa Yang, Chunying Wu, Jiunn-Chang Lin, Yan‐Hwa Wu Lee

This study identifies TIGIT-NECTIN2/3 signaling as a mechanism preserving ignorant CD8⁺ T cells in HBV-related HCC, enhancing immune checkpoint inhibitor efficacy.

bioRxiv · May 8, 2026 · PreprintImmunology